A New Look at Contraceptives

Ibsen's dictum "minorities are always right" cannot be correct: minorities seldom agree, so they cannot all be right. It would be more correct to say that "majorities are always wrong—partially if not completely." In the past, when research was usually a part-time job or a hobby, scientists were less apt than they are now to follow safe and fashionable lines of work. We were less specialized and moved from subject to subject in a manner that worried grant-giving committees then, and would

Written byNw Pirie
| 4 min read

Register for free to listen to this article
Listen with Speechify
0:00
4:00
Share

I probably changed subjects more than most. Nevertheless, in spite of a poor memory (when compared to the memories of my friends Bawden, Bernal, Miles, Haldane and Synge) and little manual dexterity, I moved reasonably smoothly along the scientific pecking order, while getting out of any subject as it began to get crowded. Such a system, or lack of system, may be epitomized as "Why do a job yourself if someone equally competent is ready to do it?" It can work— but, as with Batesian mimicry, only if it is not widely adopted.

Most research in universities and similar places does not have a clearly defined practical objective. When it has, the objective may be reached by fashionable procedures. But work along unfashionable lines is more likely to produce something unexpected and useful. Experiences in unconnected subjects may illuminate one another. That is why, as Seneca argues, innovations are more ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies